Caitlin R. Davies
London, ENG SM25GP, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Journal: Journal of medicinal chemistry
Published: March 12, 2024
Collective Synthesis of Sarpagine and Macroline Alkaloid-Inspired Compounds.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: September 17, 2023
Circulating tumour cells for early detection of clinically relevant cancer.
Journal: Nature reviews. Clinical oncology
Published: May 02, 2023
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
Journal: Frontiers in oncology
Published: October 03, 2022
Identification of a Novel Pseudo-Natural Product Type IV IDO1 Inhibitor Chemotype.
Journal: Angewandte Chemie (International ed. in English)
Published: June 27, 2022
Corrigendum: RhIII -Catalyzed C-H Activation of Aryl Hydroxamates for the Synthesis of Isoindolinones.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: November 26, 2020
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing.
Journal: Frontiers in cell and developmental biology
Published: September 03, 2020
RhIII -Catalyzed C-H Activation of Aryl Hydroxamates for the Synthesis of Isoindolinones.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: May 14, 2020
Prostate mpMRI in the UK: the state of the nation.
Journal: Clinical radiology
Published: October 20, 2019
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells.
Journal: The Journal of urology
Published: August 08, 2019
Last Updated: 09/26/2026